Cargando…

The Potential Role of Serum IGF-1 and Leptin as Biomarkers: Towards Screening for and Diagnosing Postmenopausal Osteoporosis

PURPOSE: To investigate the differences of several serum markers among population with different bone mass and to explore the utility of new potential biomarker for the diagnosing and screening for postmenopausal osteoporosis (PMOP). MATERIALS AND METHODS: A total of 1055 postmenopausal women were s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yili, Huang, Xinyi, Sun, Kai, Li, Mengyuan, Wang, Xu, Han, Tao, Shen, Hao, Qi, Baoyu, Xie, Yanming, Wei, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791302/ https://www.ncbi.nlm.nih.gov/pubmed/35095282 http://dx.doi.org/10.2147/JIR.S344009

Ejemplares similares

IL-6 and Leptin Are Potential Biomarkers for Osteoporotic Fracture Risk Assessment and Prediction of Postmenopausal Women with Low Bone Mass: A Follow-Up Study Using a Regional Sample Cohort
por: Wang, Xu, et al.
Publicado: (2022)

Baduanjin exercise: A potential promising therapy toward osteoporosis
por: Sun, Chuanrui, et al.
Publicado: (2022)

MicroRNAs in Serum Exosomes as Circulating Biomarkers for Postmenopausal Osteoporosis
por: Shi, Hongli, et al.
Publicado: (2022)

Elucidating the relationship between dyslipidemia and osteoporosis: A multicenter, prospective cohort study protocol
por: Wei, Xu, et al.
Publicado: (2022)

Understanding the Stony Bridge between Osteoporosis and Vascular Calcification: Impact of the FGF23/Klotho axis
por: Wei, Xu, et al.
Publicado: (2021)

Exploring the Relationship of Bone Turnover Markers and Bone Mineral Density in Community-Dwelling Postmenopausal Women
por: Wei, Xu, et al.
Publicado: (2021)

Calcium-Enriched Pumpkin Affects Serum Leptin Levels and Fat Content in a Rat Model of Postmenopausal Osteoporosis
por: Wawrzyniak, Natalia, et al.
Publicado: (2021)

Aberrant expression of miR-33a-3p/IGF2 in postmenopausal osteoporosis patients and its role and mechanism in osteoporosis
por: Wang, Changxin, et al.
Publicado: (2023)

Serum minerals (Ca, P, Co, Mn, Ni, Cd) and growth hormone (IGF-1 and IGF-2) levels in postmenopausal Saudi women with osteoporosis
por: Yakout, Sobhy M., et al.
Publicado: (2020)

Cytokine-scavenging nanodecoys reconstruct osteoclast/osteoblast balance toward the treatment of postmenopausal osteoporosis
por: Zhou, Yang, et al.
Publicado: (2021)

Space radiation exposure persistently increased leptin and IGF1 in serum and activated leptin-IGF1 signaling axis in mouse intestine
por: Suman, Shubhankar, et al.
Publicado: (2016)

Biomarkers of postmenopausal osteoporosis and interventive mechanism of catgut embedding in acupoints
por: Chen, Guizhen, et al.
Publicado: (2020)

Identification of gene biomarkers in patients with postmenopausal osteoporosis
por: Yang, Chenggang, et al.
Publicado: (2019)

Serum IGF1 and linear growth in children with congenital leptin deficiency before and after leptin substitution
por: Beghini, Marianna, et al.
Publicado: (2021)

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD
por: Marques, Vanda, et al.
Publicado: (2021)

Serum Bisphenol A Concentration in Postmenopausal Women with Osteoporosis
por: Kim, Dong Hyun, et al.
Publicado: (2012)

Interleukin-33 serum levels in postmenopausal women with osteoporosis
por: Ginaldi, Lia, et al.
Publicado: (2019)

The Association Between the Concentration of Serum Magnesium and Postmenopausal Osteoporosis
por: Chang, Jinlei, et al.
Publicado: (2020)

The polymorphism of Insulin-like growth factor-I (IGF-I) is related to osteoporosis and bone mineral density in postmenopausal population
por: Yun-Kai, Li, et al.
Publicado: (2014)

Adiponectin as a Biomarker of Osteoporosis in Postmenopausal Women: Controversies
por: Lubkowska, Anna, et al.
Publicado: (2014)

FOXO4 May Be a Biomarker of Postmenopausal Osteoporosis
por: Yang, Weiwei, et al.
Publicado: (2022)

Prevalence of and Risk Factors for Community-Based Osteoporosis and Associated Fractures in Beijing: Study Protocol for a Cross-Sectional and Prospective Study
por: Sun, Menghua, et al.
Publicado: (2020)

Clinical features and shared mechanisms of chronic gastritis and osteoporosis
por: Han, Tao, et al.
Publicado: (2023)

Neuropeptide Y‐Mediated Gut Microbiota Alterations Aggravate Postmenopausal Osteoporosis
por: Chen, Zhijie, et al.
Publicado: (2023)

Serum C-C Motif Ligand 11/eotaxin-1 May Serve as a Candidate Biomarker for Postmenopausal Osteoporosis
por: Wang, Wen, et al.
Publicado: (2019)

Relationship between serum uric acid levels and osteoporosis
por: Xu, Rong, et al.
Publicado: (2023)

Botanicals in Postmenopausal Osteoporosis
por: Słupski, Wojciech, et al.
Publicado: (2021)

Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review
por: Migliorini, Filippo, et al.
Publicado: (2021)

The utility of clinical decision tools for diagnosing osteoporosis in postmenopausal women with rheumatoid arthritis
por: Brand, Caroline, et al.
Publicado: (2008)

Association of dyslipidaemia with osteoporosis in postmenopausal women
por: Zhang, Lingnan, et al.
Publicado: (2021)

Serum β-Catenin Levels Associated with the Ratio of RANKL/OPG in Patients with Postmenopausal Osteoporosis
por: Xu, Xiao-Juan, et al.
Publicado: (2013)

Use of the Osteoporosis Self-Assessment Tool as a Screening Tool for Osteoporosis in Saudi Postmenopausal Women
por: Alshahrani, Fahad, et al.
Publicado: (2023)

Postmenopausal Osteoporosis Is Associated with Serum Chemerin and Irisin but Not with Apolipoprotein M Levels
por: Engin-Üstün, Yaprak, et al.
Publicado: (2016)

Discovery and Identification of Serum Succinyl‐Proteome for Postmenopausal Women with Osteoporosis and Osteopenia
por: Zhang, Li‐li, et al.
Publicado: (2019)

Decreased Serum Maresin 1 Concentration Is Associated With Postmenopausal Osteoporosis: A Cross-Sectional Study
por: Wu, Jing, et al.
Publicado: (2022)

In silico analysis of the molecular mechanism of postmenopausal osteoporosis
por: LIU, YANQING, et al.
Publicado: (2015)

Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis
por: Hu, Yunxiang, et al.
Publicado: (2022)

The contemporary look at the problem of recognizing and diagnosing postmenopausal osteoporosis and eliminating the risk of a fall
por: Janiszewska, Mariola, et al.
Publicado: (2014)

Salivary calcium as a diagnostic tool for screening of osteoporosis in postmenopausal women
por: Kumbhojkar, Shweta Vinayak, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j0pqecv261tv7ptgl522028rhh